Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Sales/Fixed Asset

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.251.240.890.760.86

What is the latest Sales/Fixed Asset ratio of NATCO PHARMA ?

The latest Sales/Fixed Asset ratio of NATCO PHARMA is 1.25 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20251.25
Mar20241.24
Mar20230.89
Mar20220.76
Mar20210.86

How is Sales/Fixed Asset of NATCO PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.25
0.81
Mar2024 1.24
39.33
Mar2023 0.89
17.11
Mar2022 0.76
-11.63
Mar2021 0.86 -

Other Financial Ratios of NATCO PHARMA


Compare Sales/Fixed Asset ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,805.6 Cr -0.8% -4% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0.8%

-4%

0.3%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses